<?xml version="1.0" encoding="UTF-8"?>
<p class="p">
 <italic class="italic">Curcuma zedoaria</italic> EO showed potent radical-scavenging effects evaluated by DPPH assay [
 <xref rid="B7-nutrients-10-01196" ref-type="bibr" class="xref">7</xref>,
 <xref rid="B23-nutrients-10-01196" ref-type="bibr" class="xref">23</xref>,
 <xref rid="B111-nutrients-10-01196" ref-type="bibr" class="xref">111</xref>,
 <xref rid="B196-nutrients-10-01196" ref-type="bibr" class="xref">196</xref>,
 <xref rid="B197-nutrients-10-01196" ref-type="bibr" class="xref">197</xref>]. The strong antioxidant activity of 
 <italic class="italic">C. zedoaria</italic> EO is utilized in the food industry to minimize or prevent lipid oxidation. Zedoary EO also showed potent, selective cytotoxic activity and inhibited the proliferation of human cervical cancer (SiHa), colorectal cancer (SNU-1), human hepatoma (HepG2) [
 <xref rid="B198-nutrients-10-01196" ref-type="bibr" class="xref">198</xref>], human gastric adenocarcinoma (AGS) [
 <xref rid="B114-nutrients-10-01196" ref-type="bibr" class="xref">114</xref>], hepatic stellate cells [
 <xref rid="B110-nutrients-10-01196" ref-type="bibr" class="xref">110</xref>], mouse melanoma (B16BL6) cells, human hepatoma (SMMC-7721) cells, and HL-60 cells [
 <xref rid="B7-nutrients-10-01196" ref-type="bibr" class="xref">7</xref>,
 <xref rid="B110-nutrients-10-01196" ref-type="bibr" class="xref">110</xref>]. It is worth noting that normal endothelial cells were less sensitive to zedoary EO than cancer cells in the in vitro assays [
 <xref rid="B200-nutrients-10-01196" ref-type="bibr" class="xref">200</xref>]. The cytotoxic activity of zedoary EO is mediated by efficiently inhibiting monocytic differentiation, inhibiting cell proliferation, arresting cell cycle and inducing apoptosis [
 <xref rid="B109-nutrients-10-01196" ref-type="bibr" class="xref">109</xref>,
 <xref rid="B110-nutrients-10-01196" ref-type="bibr" class="xref">110</xref>,
 <xref rid="B234-nutrients-10-01196" ref-type="bibr" class="xref">234</xref>]. The oil exhibited efficient cytotoxic effects against nonsmall cell lung carcinoma (NSCLC) cells via inducing apoptosis [
 <xref rid="B199-nutrients-10-01196" ref-type="bibr" class="xref">199</xref>]. Zedoary EO showed antiproliferative activity against human colon-cancer cells (HCT116) by causing senescence and apoptosis in a dose- and time-dependent manner [
 <xref rid="B235-nutrients-10-01196" ref-type="bibr" class="xref">235</xref>]. Zedoary EO in a combination with paclitaxel synergistically enhanced their antitumor activity and increased the apoptosis of human ovarian cancer (SKOV3) cells [
 <xref rid="B202-nutrients-10-01196" ref-type="bibr" class="xref">202</xref>]. Zedoary EO (i.p.) significantly inhibited the growth of human lung-cancer cells (H1299) in vivo via inhibiting protein kinase B (Akt)/nuclear factor-kappa B (NF-ÎºB) signaling pathways [
 <xref rid="B199-nutrients-10-01196" ref-type="bibr" class="xref">199</xref>]. Zedoary EO was reported to inhibit angiogenesis in vitro and in vivo, which results in tumor inhibition [
 <xref rid="B200-nutrients-10-01196" ref-type="bibr" class="xref">200</xref>]. Zedoary EO strongly inhibits vascular endothelial growth factor (VEGF)-induced angiogenesis in vitro and tumor angiogenesis in vivo via downregulating matrix metalloproteinases [
 <xref rid="B200-nutrients-10-01196" ref-type="bibr" class="xref">200</xref>]. In rodent experiments, zedoary oil showed antitumor action in hepatoma-transplanted rats [
 <xref rid="B203-nutrients-10-01196" ref-type="bibr" class="xref">203</xref>]. In addition, it has been used clinically in China for treating hepatic carcinoma [
 <xref rid="B201-nutrients-10-01196" ref-type="bibr" class="xref">201</xref>]. In China, zedoary oil is used for treating gynecologic inflammation, monilial vaginitis, and tumors [
 <xref rid="B236-nutrients-10-01196" ref-type="bibr" class="xref">236</xref>]. Zedoary EO is also known for its hypoglycemic effects [
 <xref rid="B204-nutrients-10-01196" ref-type="bibr" class="xref">204</xref>]. In a study performed on streptozotocin-induced hyperglycemic Wistar rats, oral administration of the oil for seven days was able to significantly decrease blood-glucose levels and prevent gingivitis [
 <xref rid="B204-nutrients-10-01196" ref-type="bibr" class="xref">204</xref>]. Zedoary EO has been used for oral-health maintenance because of its antimicrobial, hypoglycemic, and anti-inflammatory properties [
 <xref rid="B14-nutrients-10-01196" ref-type="bibr" class="xref">14</xref>], which can help in reducing gingival inflammation. Zedoary EO exhibited antimicrobial activity against 
 <italic class="italic">Vibrio parahaemolyticus</italic>, 
 <italic class="italic">Staphylococcus aureus</italic>, 
 <italic class="italic">Bacillus cereus</italic>, 
 <italic class="italic">Salmonella typhimurium</italic>, and 
 <italic class="italic">Pseudomonas aeruginosa</italic> [
 <xref rid="B110-nutrients-10-01196" ref-type="bibr" class="xref">110</xref>]. It also demonstrated antifungal activity against 
 <italic class="italic">Colletotrichum falcatum</italic> [
 <xref rid="B37-nutrients-10-01196" ref-type="bibr" class="xref">37</xref>] and good insecticidal activity against the sugarcane pest, 
 <italic class="italic">Odontotermes obesus</italic> Rhamb [
 <xref rid="B37-nutrients-10-01196" ref-type="bibr" class="xref">37</xref>]. Zedoary oil displayed larvicidal effects against the malaria vector, 
 <italic class="italic">Anopheles dirus</italic> (LC
 <sub class="sub">50</sub> = 29.69 ppm), and the hemorrhagic fever vector, 
 <italic class="italic">Aedes aegypti</italic> (LC
 <sub class="sub">50</sub> = 31.87 ppm) [
 <xref rid="B129-nutrients-10-01196" ref-type="bibr" class="xref">129</xref>].
</p>
